hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy

BACKGROUND: The identification of early-stage colorectal cancer (CRC) with high risk of progression is one major clinical challenge, mainly due to lack of validated biomarkers. The aims of the present study were to analyze the prognostic impact of three molecular markers belonging to the ion channel...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Muratori, Leonardo, Petroni, Giulia, Antonuzzo, Lorenzo, Boni, Luca, Iorio, Jessica, Lastraioli, Elena, Bartoli, Gianluca, Messerini, Luca, Di Costanzo, Francesco, Arcangeli, Annarosa
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2016
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5072508/
https://ncbi.nlm.nih.gov/pubmed/27789963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S114090
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker